TY - JOUR T1 - Aspirin given for up to 2 years after initial anticoagulant treatment reduces the risk of venous thromboembolism recurrence without increasing risk of major bleeding JF - Evidence Based Nursing JO - Evid Based Nurs DO - 10.1136/eb-2012-100896 SP - ebnurs-2012-100896 AU - Henry G Watson Y1 - 2012/11/01 UR - http://ebn.bmj.com/content/early/2012/11/22/eb-2012-100896.abstract N2 - The use of aspirin to prevent recurrent venous thromboembolism (VTE) after a first idiopathic event should not currently become a standard practice. Further studies are required before the use of aspirin following anticoagulation with warfarin for a first episode of venous thromboembolism becomes adopted as routine clinical practice. A direct comparison between low-dose aspirin and standard intensity warfarin is required. Venous thromboembolism, which encompasses deep vein thrombosis and pulmonary embolism, is a relatively common disorder with an incidence in western countries of around 1/1000 per annum.1 Events are categorised as either provoked, that is occurring in the context of a known temporary risk factor such as surgery, or unprovoked, that is occurring without an associated known risk factor. There is a general consensus that provoked events have a low … ER -